New G-CSF agonists for neutropenia therapy

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.23, Iss.1, 2014-01, pp. : 21-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

G-CSF reduces febrile neutropenia and mortality risk

Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

G-CSF as prophylaxis of febrile neutropenia in SCLC

By Feinglass Joe Adams Jared R Djubegovic Benjamin Bennett Charles L Lyman Gary H

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 9, 2002-09 ,pp. : 1273-1281

Informa Healthcare

Access to resources Recommend Favorite

G-CSF linked to GVHD

Reactions Weekly, Vol. 1, Iss. 1327, 2010-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Granulocyte colony-stimulating factor (G-CSF) appears to increase the risk of therapy-related myeloid leukaemia

Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Pleiotropic Effects of Cytokines on Acute Myocardial Infarction: G-CSF as A Novel Therapy for Acute Myocardial Infarction

Current Pharmaceutical Design, Vol. 9, Iss. 14, 2003-05 ,pp. : 1121-1127

Bentham Science Publishers

Access to resources Recommend Favorite